Nick Maynard
Overview
Explore the profile of Nick Maynard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1017
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
LAsting Symptoms after Oesophageal Resectional Surgery (LASORS): multicentre validation cohort study
Paine H, Chidambaram S, Johar A, Maynard N, Lagergren P, Griffiths E, et al.
Br J Surg
. 2025 Feb;
112(2).
PMID: 39982378
Background: Long-term symptom burden and health-related quality-of-life outcomes after curative oesophageal cancer treatment are poorly understood. Existing tools are cumbersome and do not address the post-treatment population specifically. The aim...
2.
Markar S, Sgromo B, Evans R, Griffiths E, Alfieri R, Castoro C, et al.
Ann Surg
. 2024 Jun;
280(4):650-658.
PMID: 38904105
Objective: To evaluate prognostic differences between minimally invasive esophagectomy (MIE) and open esophagectomy (OE) in patients with surgery after a prolonged interval (>12 wk) following chemoradiotherapy (CRT). Background: Previously, we...
3.
Down B, Lakunina S, Maynard N, Markar S, Gordon-Weeks A
Eur J Surg Oncol
. 2024 Mar;
50(4):108231.
PMID: 38461569
Oligometastatic oesophagogastric cancer was recently defined by consensus as the presence of no more than two metastases and an 18-week period of oncological stability during chemotherapy. The number of patients...
4.
Musa A, Crawley J, Haj-Hassan T, Inglis R, Maynard N
Lancet
. 2023 Dec;
402(10419):2292-2293.
PMID: 38043554
No abstract available.
5.
Smith J, Abdel-Mannan O, Abuelaish I, Kelly B, Maynard N
Lancet
. 2023 Nov;
402(10416):1974-1975.
PMID: 37956690
No abstract available.
6.
Chidambaram S, Owen R, Sgromo B, Chmura M, Kisiel A, Evans R, et al.
Ann Surg
. 2023 Jul;
278(5):701-708.
PMID: 37477039
Objective: To determine the impact of delayed surgical intervention following chemoradiotherapy (CRT) on survival from esophageal cancer. Background: CRT is a core component of multimodality treatment for locally advanced esophageal...
7.
Markar S, Guazzelli A, Taylor A, Jones L, Dutton S, Jogarah V, et al.
Br J Surg
. 2023 Jun;
110(10):1359-1360.
PMID: 37376769
No abstract available.
8.
Menon N, Guidozzi N, Chidambaram S, Puri A, Sounderajah V, Ferri L, et al.
Dis Esophagus
. 2023 May;
36(10).
PMID: 37158194
Large hiatus hernias with a significant paraesophageal component (types II-IV) have a range of insidious symptoms. Management of symptomatic hernias includes conservative treatment or surgery. Currently, there is no paraesophageal...
9.
Owen R, Chidambaram S, Griffiths E, Sultan J, Phillips A, Vohra R, et al.
Ann Surg
. 2023 Apr;
278(6):910-917.
PMID: 37114497
Objective: To identify prognostic factors associated with 90-day mortality in patients with oesophageal perforation (OP), and characterize the specific timeline from presentation to intervention, and its relation to mortality. Background:...
10.
Pucher P, Park M, Cromwell D, Crosby T, Thomas B, Trudgill N, et al.
Br J Surg
. 2023 Mar;
110(6):701-709.
PMID: 36972221
Background: The National Oesophago-Gastric Cancer Audit (NOGCA) captures patient data from diagnosis to end of primary treatment for all patients with oesophagogastric (OG) cancer in England and Wales. This study...